Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit is the industry’s definitive and only meeting focused on tackling the greatest analytical development challenges in the context of gene therapy drug development. Hear from the likes of AstraZeneca, MHRA, Gyroscope, REGENXBIO, Biogen, Spark Therapeutics, and more […]

Facilitating key conversations needed to drive forward the development of safe and effective innate stimulating immunotherapies, the 4th STING & TLR Targeting Therapies Summit will take place, for the first time ever in person, in Boston on May 9-11, 2023. View the official program here. Explore innate agonists from discovery to translation with the leaders in the space and […]

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along with the increase in associated toxicities, are driving requirements for more effective containment solutions and much-needed guidelines to ensure worker safety. Our 2023 conference brings […]

Exploring Injectable Drug Formulations and Device Development Sponsors: Victrex Exhibitors: PHC Group  As Part of Europe’s leading Injectable conference series, the 5th annual Injectable Drug Delivery conference will assess innovations in drug product formulation and biologics, new technologies in device design, along with the latest regulatory considerations for optimal drug delivery. With increasing demand for […]

It’s a painful moment for healthcare. We face rampant burn out, squeezed operating margins, unhappy patients, massive cost pressures and more competition than ever as disruptors continue to flood the market with convenient, accessible care options. It’s high time we collaborate around Digital Health. We must listen, take note and work to implement the changes […]

With 3 days of jam-packed content and 35+ world class speakers pioneering the next wave of ALS therapies, the 2nd ALS Drug Development Summit is biopharma’s can’t-miss meeting for the acceleration of ALS drug development pipelines. Join 100+ of your biopharma peers to uncover cutting-edge ALS biomarkers, including neurofilament light chain, to incorporate into clinical trials, improve in vitro and in vivo ALS […]

With investment into the Treg field at an all time high, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of autoimmunity, inflammation and transplantation. As this enthusiasm coincides with multiple clinical readouts and several more therapies entering the clinic, it remains vital for Treg trailblazers to come together to recognize therapy efficacy, determine […]

The 2nd Cell Therapy Potency Assay will gather 100+ experts working to rationally design better potency assays to smooth the path to regulatory approval and minimize hold times with scientifically rigorous and informative potency measurements. Whether you are submitting your first IND or gearing up towards BLA submission, this critical meeting of minds is your premier opportunity to join the likes […]

Whether it’s in cardiovascular disease, Alzheimer’s or osteoarthritis, therapeutic innovations to target the mechanisms of aging are making significant headway to clinical trials. With increased investments and recognition, along with the escalation of the burden of age-related disease, research and development to meet this unmet medical need has never been more important. The 5th Age-Related Disease Therapeutics Summit is […]